EyePoint Pharmaceuticals, Inc. Quarterly Common Stock, Shares, Issued from Q2 2011 to Q2 2024

Taxonomy & unit
us-gaap: shares
Description
Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.
Summary
EyePoint Pharmaceuticals, Inc. quarterly Common Stock, Shares, Issued history and growth rate from Q2 2011 to Q2 2024.
  • EyePoint Pharmaceuticals, Inc. Common Stock, Shares, Issued for the quarter ending June 30, 2024 was 52.2M shares, a 52% increase year-over-year.
Common Stock, Shares, Issued, Quarterly (shares)
Common Stock, Shares, Issued, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 52.2M +17.9M +52% Jun 30, 2024 10-Q 2024-08-08
Q1 2024 49.9M +15.6M +45.4% Mar 31, 2024 10-Q 2024-05-09
Q4 2023 49M +15M +43.9% Dec 31, 2023 10-Q 2024-08-08
Q3 2023 35.3M +1.24M +3.63% Sep 30, 2023 10-Q 2023-11-03
Q2 2023 34.3M +254K +0.74% Jun 30, 2023 10-Q 2023-08-04
Q1 2023 34.3M +255K +0.75% Mar 31, 2023 10-Q 2023-05-04
Q4 2022 34.1M +177K +0.52% Dec 31, 2022 10-K 2024-03-08
Q3 2022 34.1M +5.3M +18.4% Sep 30, 2022 10-Q 2022-11-04
Q2 2022 34.1M +5.3M +18.4% Jun 30, 2022 10-Q 2022-08-05
Q1 2022 34M +5.31M +18.5% Mar 31, 2022 10-Q 2022-05-06
Q4 2021 33.9M +15.8M +86.9% Dec 31, 2021 10-K 2023-03-10
Q3 2021 28.8M -103M -78.1% Sep 30, 2021 10-Q 2021-11-05
Q2 2021 28.8M -96.4M -77% Jun 30, 2021 10-Q 2021-08-06
Q1 2021 28.7M -96M -77% Mar 31, 2021 10-Q 2021-05-05
Q4 2020 18.1M +7.2M +65.8% Dec 31, 2020 10-K 2022-03-14
Q3 2020 131M +23.4M +21.7% Sep 30, 2020 10-Q 2020-11-06
Q2 2020 125M +18.9M +17.8% Jun 30, 2020 10-Q 2020-08-05
Q1 2020 125M +29.2M +30.5% Mar 31, 2020 10-Q 2020-05-08
Q4 2019 10.9M -84.4M -88.5% Dec 31, 2019 10-K 2021-03-12
Q3 2019 108M +13.3M +14.1% Sep 30, 2019 10-Q 2019-11-07
Q2 2019 106M +31.8M +42.7% Jun 30, 2019 10-Q 2019-08-07
Q1 2019 95.6M +41.6M +77.2% Mar 31, 2019 10-Q 2019-05-10
Q4 2018 95.4M +50.1M +111% Dec 31, 2018 10-K 2020-03-16
Q3 2018 94.7M +54.5M +136% Sep 30, 2018 10-Q 2018-11-09
Q2 2018 74.5M +35.2M +89.3% Jun 30, 2018 10-KT 2019-03-18
Q1 2018 53.9M +18.2M +51.1% Mar 31, 2018 10-Q 2018-05-10
Q4 2017 45.3M +11.1M +32.4% Dec 31, 2017 10-Q 2018-02-08
Q3 2017 40.2M +6.02M +17.6% Sep 30, 2017 10-Q 2017-11-08
Q2 2017 39.4M +5.18M +15.2% Jun 30, 2017 10-KT 2019-03-18
Q1 2017 35.7M +1.59M +4.65% Mar 31, 2017 10-Q 2017-05-08
Q4 2016 34.2M +4.55M +15.4% Dec 31, 2016 10-Q 2017-02-09
Q3 2016 34.2M +4.76M +16.2% Sep 30, 2016 10-Q 2016-11-08
Q2 2016 34.2M +4.76M +16.2% Jun 30, 2016 10-K 2017-09-13
Q1 2016 34.1M +4.67M +15.9% Mar 31, 2016 10-Q 2016-05-06
Q4 2015 29.6M +216K +0.73% Dec 31, 2015 10-Q 2016-02-09
Q3 2015 29.4M +79.8K +0.27% Sep 30, 2015 10-Q 2015-11-06
Q2 2015 29.4M +114K +0.39% Jun 30, 2015 10-K 2016-09-13
Q1 2015 29.4M +168K +0.57% Mar 31, 2015 10-Q 2015-05-08
Q4 2014 29.4M +2.11M +7.74% Dec 31, 2014 10-Q 2015-02-06
Q3 2014 29.3M +2.55M +9.5% Sep 30, 2014 10-Q 2014-11-07
Q2 2014 29.3M +6M +25.8% Jun 30, 2014 10-K 2015-09-10
Q1 2014 29.2M +5.95M +25.5% Mar 31, 2014 10-Q 2014-05-14
Q4 2013 27.3M +4M +17.2% Dec 31, 2013 10-Q 2014-02-12
Q3 2013 26.8M +3.49M +15% Sep 30, 2013 10-Q 2013-11-13
Q2 2013 23.3M +2.49M +12% Jun 30, 2013 10-K 2014-09-11
Q1 2013 23.3M +2.49M +12% Mar 31, 2013 10-Q 2013-05-14
Q4 2012 23.3M +2.49M +12% Dec 31, 2012 10-Q 2013-02-08
Q3 2012 23.3M +2.49M +12% Sep 30, 2012 10-Q 2012-11-09
Q2 2012 20.8M +54K +0.26% Jun 30, 2012 10-K 2013-09-27
Q1 2012 20.8M Mar 31, 2012 10-Q 2012-05-10
Q4 2011 20.8M Dec 31, 2011 10-Q 2012-02-09
Q3 2011 20.8M Sep 30, 2011 10-Q/A 2011-11-09
Q2 2011 20.7M Jun 30, 2011 10-K 2012-09-27
* An asterisk sign (*) next to the value indicates that the value is likely invalid.